Annual D&A
$1.07 M
+$337.30 K+45.86%
December 1, 2022
Summary
- As of March 10, 2025, CERO annual depreciation & amortization is $1.07 million, with the most recent change of +$337.30 thousand (+45.86%) on December 1, 2022.
- During the last 3 years, CERO annual D&A has risen by +$337.30 thousand (+45.86%).
- CERO annual D&A is now at all-time high.
Performance
CERO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
September 1, 2024
Summary
- CERO quarterly depreciation & amortization is not available.
Performance
CERO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
September 1, 2024
Summary
- CERO TTM depreciation & amortization is not available.
Performance
CERO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
CERO Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.9% | - | - |
| 3 y3 years | +45.9% | - | - |
| 5 y5 years | +45.9% | - | - |
CERO Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.9% | ||||
| 5 y | 5-year | at high | +45.9% | ||||
| alltime | all time | at high | +45.9% |
CERo Therapeutics Holdings Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $281.40 K(+1.4%) | $832.50 K(+51.1%) |
| Jun 2023 | - | $277.50 K(+1.4%) | $551.10 K(+101.4%) |
| Mar 2023 | - | $273.60 K | $273.60 K |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $1.07 M(+45.9%) | - | - |
| Mar 2022 | - | $251.40 K | $251.40 K |
| Dec 2021 | $735.50 K | - | - |
FAQ
- What is CERo Therapeutics Holdings annual depreciation & amortization?
- What is the all time high annual D&A for CERo Therapeutics Holdings?
- What is CERo Therapeutics Holdings annual D&A year-on-year change?
- What is the all time high quarterly D&A for CERo Therapeutics Holdings?
- What is the all time high TTM D&A for CERo Therapeutics Holdings?
What is CERo Therapeutics Holdings annual depreciation & amortization?
The current annual D&A of CERO is $1.07 M
What is the all time high annual D&A for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high annual depreciation & amortization is $1.07 M
What is CERo Therapeutics Holdings annual D&A year-on-year change?
Over the past year, CERO annual depreciation & amortization has changed by +$337.30 K (+45.86%)
What is the all time high quarterly D&A for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high quarterly depreciation & amortization is $281.40 K
What is the all time high TTM D&A for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high TTM depreciation & amortization is $832.50 K